Town Health International Medical Group Limited Issues Positive Profit Alert for FY2025

Date: 10 March 2026

Company: Town Health International Medical Group Limited (Stock Code: 3886)

Key Highlights

• Return to Profitability: For the year ended 31 December 2025, Town Health International Medical Group Limited (the “Company”) expects to record a significant turnaround, reporting a profit in the range of approximately HK\$45.2 million to HK\$71.0 million. This includes a profit attributable to shareholders of about HK\$10.4 million to HK\$16.3 million, in stark contrast to a loss of HK\$158.2 million (and loss attributable to shareholders of HK\$203.7 million) for the year ended 31 December 2024.
• Major Factors Driving the Turnaround:
  • Decrease in Fair Value Loss: The fair value loss of the Group’s investment properties has dropped significantly compared to 2024.
  • Lower Impairment Losses on Associates: Impairment losses recognised on interests in associates have decreased from the prior year.
  • Lower Impairment Losses on Goodwill: Impairment losses on the Group’s goodwill have also reduced.
  • Share of Profits from Associates: The Group expects to record a share of profits from associates, versus a share of losses in 2024.
• Operating Profit (Excluding “Other Gains and Losses, Net”):
  • If “other gains and losses, net” are excluded, the Group anticipates an operating profit in the range of HK\$61.3 million to HK\$96.3 million, with operating profit attributable to shareholders between HK\$26.5 million and HK\$41.6 million for 2025.
  • This is an improvement from the operating profit of HK\$70.9 million (attributable: HK\$25.4 million) recorded in storage for 2024, reflecting robust business operations.

Potential Price-Sensitive Information

• Material Turnaround: The dramatic swing from a large loss in 2024 to a notable profit in 2025 could impact investor sentiment and potentially drive share price movements.
• Asset Valuation and Adjustments: The Group is still finalising assessments and valuations of its relevant assets. Final results could lead to further adjustments for FY2025, which may affect the final reported profit.
• Provisional Figures: The announcement is based on preliminary data, not yet reviewed or audited. Finalised annual results will be disclosed in the upcoming annual results announcement for the year ended 31 December 2025.

Important Information for Shareholders and Investors

• Exercise Caution: Shareholders and potential investors are advised to exercise caution when dealing in the shares of the Company, given the preliminary nature of the figures and ongoing asset assessments.
• Further Announcements: More details, including audited financials, will be published upon finalisation of the annual results.

Board and Management

The announcement has been authorised by the Board, led by Mr. Choi Ka Tsan Karson, GBS, JP (Chairman and CEO), and supported by a diverse group of Executive, Non-Executive, and Independent Non-Executive Directors.

Disclaimer

The above article is based on a company announcement and contains forward-looking statements subject to risks and uncertainties. Actual results may differ materially from those projected. Investors are advised to consult the full annual results and seek professional advice before making investment decisions. This article does not constitute investment advice.

View TOWN HEALTH Historical chart here